FLXN · Horizon Flexible Income ETF

-

Please sign in to comment on FLXN

1 Comment

Admin

4 years, 4 months ago

Flexion Therapeutics, Inc is currently in a long term downtrend where the price is trading 26.1% below its 200 day moving average.

From a valuation standpoint, the stock is 99.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 4.7.

Flexion Therapeutics, Inc's total revenue rose by 11.2% to $26M since the same quarter in the previous year.

Its net income has increased by 41.4% to $-20M since the same quarter in the previous year.

Finally, its free cash flow grew by 73.7% to $-11M since the same quarter in the previous year.

Based on the above factors, Flexion Therapeutics, Inc gets an overall score of 4/5.

ISIN	US33938J1060
Sector	Healthcare
Industry	Drug Manufacturers - Specialty & Generic
Exchange	NASDAQ
CurrencyCode	USD

Market Cap	459M
PE Ratio	None
Target Price	27
Dividend Yield	0.0%
Beta	nan

ABOUT

Horizon Flexible Income ETF

The fund is an actively managed ETF that seeks to achieve its investment objective by investing primarily in non-investment grade Fixed Income Instruments. The fund"s Fixed Income Instruments may include debt or debt-related securities, income producing securities, and other instruments or evidences of indebtedness, including bonds, bills, notes, loans, money market instruments, mortgage and asset backed securities, and preferred stocks, and derivative instruments related thereto; and other investment companies that invest primarily in the foregoing instruments.

FLXN · Horizon Flexible Income ETF

-

Horizon Flexible Income ETF

Earnings

Valuation

Cash Flow

Profitability

Performance

Backtest Horizon Flexible Income ETF using a moving average strategy